Eli Lilly vs Amgen: Revenue Comparison
Eli Lilly (LLY) and Amgen (AMGN) are peers in GLP-1. Eli Lilly reported revenue of $19.8B as of Q1 2026, compared with $8.6B for Amgen. Eli Lilly leads on revenue.
Eli Lilly's gross margin is 81.9% versus 68.2% for Amgen. Eli Lilly's net margin is 37.4% versus 21.1% for Amgen.
Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q1 2026: Eli Lilly 19.799, Amgen 8.618.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Eli Lilly, Amgen.| Metric | Eli Lilly | Amgen |
|---|---|---|
| Market Cap | - | - |
| Revenue | $19.80B | $8.62B |
| Cost of Revenue | $3.58B | $2.74B |
| Gross Profit | $16.22B | $5.87B |
| Operating Income | $8.85B | $2.67B |
| Net Income | $7.40B | $1.82B |
| R&D Expense | $3.51B | $1.72B |
| Earnings Per Share | $8.26 | $3.34 |
| Gross Margin | 81.9% | 68.2% |
| Operating Margin | 44.7% | 30.9% |
| Net Profit Margin | 37.4% | 21.1% |
| Free Cash Flow | $3.01B | $1.48B |
| Cumulative Free Cash Flow | $101.90B | $165.69B |
| Operating Cash Flow | $5.33B | $2.19B |
| Cash & Equivalents | $5.14B | $12.04B |